{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:29Z","timestamp":1772165669122,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The trial was funded by: the National Science and Technology Major Project of China during the 13th Five-year plan period","award":["2018ZX10302104"],"award-info":[{"award-number":["2018ZX10302104"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860114"],"award-info":[{"award-number":["81860114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau","award":["2020MSXM097"],"award-info":[{"award-number":["2020MSXM097"]}]},{"name":"the Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau","award":["2022QNXM032"],"award-info":[{"award-number":["2022QNXM032"]}]},{"name":"the medical scientific research project of Chongqing Health Commission","award":["2022WSJK037"],"award-info":[{"award-number":["2022WSJK037"]}]},{"name":"the Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau","award":["2020FYYX066"],"award-info":[{"award-number":["2020FYYX066"]}]},{"name":"the Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau","award":["2020FYYX161"],"award-info":[{"award-number":["2020FYYX161"]}]},{"name":"the Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau","award":["2018MSXM013"],"award-info":[{"award-number":["2018MSXM013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study\u2019s objective was to investigate the predictors for severe anemia, severe leukopenia, and severe thrombocytopenia when amphotericin B deoxycholate-based induction therapy is used in HIV-infected patients with talaromycosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 170 HIV-infected patients with talaromycosis were enrolled from January 1st, 2019, to September 30th, 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Approximately 42.9%, 20.6%, and 10.6% of the enrolled patients developed severe anemia, severe leukopenia, and severe thrombocytopenia, respectively. Baseline hemoglobin level\u2009&lt;\u2009100\u00a0g\/L (OR\u2009=\u20095.846, 95% CI: 2.765\u2009~\u200912.363), serum creatinine level\u2009&gt;\u200973.4 \u00b5mol\/L (OR\u2009=\u20092.573, 95% CI: 1.157\u2009~\u20095.723), AST\/ALT ratio\u2009&gt;\u20091.6 (OR\u2009=\u20092.479, 95% CI: 1.167\u2009~\u20095.266), sodium level\u2009\u2264\u2009136 mmol\/liter (OR\u2009=\u20094.342, 95% CI: 1.747\u2009~\u200910.789), and a dose of amphotericin B deoxycholate\u2009&gt;\u20090.58\u00a0mg\/kg\/d (OR\u2009=\u20092.504, 95% CI:1.066\u2009~\u20095.882) were observed to be independent risk factors associated with the development of severe anemia. Co-infection with tuberculosis (OR\u2009=\u20093.307, 95% CI: 1.050\u2009~\u200910.420), and platelet level (per 10\u2009\u00d7\u2009109 \/L) (OR\u2009=\u20090.952, 95% CI: 0.911\u2009~\u20090.996) were shown to be independent risk factors associated with the development of severe leukopenia. Platelet level\u2009&lt;\u2009100\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L (OR\u2009=\u20092.935, 95% CI: 1.075\u2009~\u20098.016) was identified as the independent risk factor associated with the development of severe thrombocytopenia. There was no difference in progression to severe anemia, severe leukopenia, and severe thrombocytopenia between the patients with or without fungal clearance at 2 weeks. 10\u00a0mg on the first day of amphotericin B deoxycholate was calculated to be independent risk factors associated with the development of severe anemia (OR\u2009=\u20092.621, 95% CI: 1.107\u2009~\u20096.206). The group receiving a starting amphotericin B dose (10\u00a0mg, 20\u00a0mg, daily) exhibited the highest fungal clearance rate at 96.3%, which was significantly better than the group receiving a starting amphotericin B dose (5\u00a0mg, 10\u00a0mg, 20\u00a0mg, daily) (60.9%) and the group receiving a starting amphotericin B dose (5\u00a0mg, 15\u00a0mg, and 25\u00a0mg, daily) (62.9%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The preceding findings reveal risk factors for severe anemia, severe leukopenia, and severe thrombocytopenia. After treatment with Amphotericin B, these severe adverse events are likely unrelated to fungal clearance at 2 weeks. Starting amphotericin B deoxycholate at a dose of 10\u00a0mg on the first day may increase the risk of severe anemia but can lead to earlier fungal clearance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ChiCTR1900021195. Registered 1 February 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08394-7","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T01:02:03Z","timestamp":1697763723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yihong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Harypursat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shide","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3229-0108","authenticated-orcid":false,"given":"Yaokai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"issue":"2","key":"8394_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/myc.13206","volume":"64","author":"Y Qin","year":"2021","unstructured":"Qin Y, Zhou Y, Lu Y, Chen H, Jiang Z, He K, et al. Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV-infected patients with talaromycosis. Mycoses. 2021;64(2):203\u201311.","journal-title":"Mycoses"},{"issue":"1","key":"8394_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12879-020-05260-8","volume":"20","author":"Y Qin","year":"2020","unstructured":"Qin Y, Huang X, Chen H, Liu X, Li Y, Hou J, et al. Burden of Talaromyces marneffei infection in people living with HIV\/AIDS in Asia during ART era: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):551.","journal-title":"BMC Infect Dis"},{"issue":"24","key":"8394_CR3","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1056\/NEJMoa1613306","volume":"376","author":"T Le","year":"2017","unstructured":"Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, et al. A trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. N Engl J Med. 2017;376(24):2329\u201340.","journal-title":"N Engl J Med"},{"key":"8394_CR4","doi-asserted-by":"publisher","first-page":"586390","DOI":"10.3389\/fmed.2020.586390","volume":"7","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yang Z, Liu M, Lu Y, Qin Y, He X, et al. Independent risk factors for deaths due to AIDS in Chongqing, China: does Age Matter? Front Med (Lausanne). 2020;7:586390.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"8394_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/hiv.13024","volume":"21","author":"RS Ying","year":"2020","unstructured":"Ying RS, Le T, Cai WP, Li YR, Luo CB, Cao Y, et al. Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011\u20132017. HIV Med. 2020;21(11):729\u201338.","journal-title":"HIV Med"},{"issue":"4","key":"8394_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/jinf.2002.1062","volume":"45","author":"KH Ranjana","year":"2002","unstructured":"Ranjana KH, Priyokumar K, Singh TJ, Gupta Ch C, Sharmila L, Singh PN, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002;45(4):268\u201371.","journal-title":"J Infect"},{"key":"8394_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.1964.03070090013003","volume":"189","author":"MW Brandriss","year":"1964","unstructured":"Brandriss MW, Wolff SM, Moores R, Stohlman F. Jr. Anemia induced by amphotericin B. JAMA. 1964;189:663\u20136.","journal-title":"JAMA"},{"issue":"Suppl 7","key":"8394_CR8","doi-asserted-by":"publisher","first-page":"27s","DOI":"10.1016\/j.amjmed.2003.12.010","volume":"116","author":"PS Belperio","year":"2004","unstructured":"Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116(Suppl 7):27s\u201343s.","journal-title":"Am J Med"},{"issue":"6","key":"8394_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/QAD.0000000000002171","volume":"33","author":"S Albrecht","year":"2019","unstructured":"Albrecht S, Franzeck FC, Mapesi H, Hatz C, Kalinjuma AV, Glass TR, et al. Age-related comorbidities and mortality in people living with HIV in rural Tanzania. Aids. 2019;33(6):1031\u201341.","journal-title":"Aids"},{"issue":"6","key":"8394_CR10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.4269\/ajtmh.18-0096","volume":"100","author":"BA Haider","year":"2019","unstructured":"Haider BA, Spiegelman D, Hertzmark E, Sando D, Duggan C, Makubi A, et al. Anemia, Iron Deficiency, and Iron Supplementation in Relation to Mortality among HIV-Infected patients receiving highly active antiretroviral therapy in Tanzania. Am J Trop Med Hyg. 2019;100(6):1512\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"8394_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/516120","volume":"25","author":"MR Yeaman","year":"1997","unstructured":"Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis. 1997;25(5):951\u201368. quiz 69\u201370.","journal-title":"Clin Infect Dis"},{"key":"8394_CR12","doi-asserted-by":"publisher","first-page":"634386","DOI":"10.3389\/fimmu.2021.634386","volume":"12","author":"M Madzime","year":"2021","unstructured":"Madzime M, Rossouw TM, Theron AJ, Anderson R, Steel HC. Interactions of HIV and antiretroviral therapy with neutrophils and platelets. Front Immunol. 2021;12:634386.","journal-title":"Front Immunol"},{"issue":"2","key":"8394_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen AF, Kayser O, Amphotericin B. Appl Microbiol Biotechnol. 2005;68(2):151\u201362.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"10","key":"8394_CR14","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3109\/10428194.2015.1010080","volume":"56","author":"DR Falci","year":"2015","unstructured":"Falci DR, da Rosa FB, Pasqualotto AC. Hematological toxicities associated with amphotericin B formulations. Leuk Lymphoma. 2015;56(10):2889\u201394.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"8394_CR15","first-page":"1575","volume":"11","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Qin Y, Lu Y, et al. Efficacy and safety of Voriconazole Versus amphotericin B deoxycholate induction treatment for HIV-Associated Talaromycosis: a prospective Multicenter Cohort Study in China. Infect Dis Ther. 2022;11(4):1575\u201390.","journal-title":"Infect Dis Ther"},{"issue":"7","key":"8394_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/cid\/cir028","volume":"52","author":"T Le","year":"2011","unstructured":"Le T, Wolbers M, Chi NH, Quang VM, Chinh NT, Lan NP, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clin Infect Dis. 2011;52(7):945\u201352.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8394_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12291-010-0080-4","volume":"25","author":"M Kannapiran","year":"2010","unstructured":"Kannapiran M, Nisha D, Madhusudhana Rao A. Underestimation of impaired kidney function with serum creatinine. Indian J Clin Biochem. 2010;25(4):380\u20134.","journal-title":"Indian J Clin Biochem"},{"issue":"12","key":"8394_CR18","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1089\/aid.2011.0188","volume":"28","author":"AG Abraham","year":"2012","unstructured":"Abraham AG, Palella FJ, Li X, Estrella MM, Kingsley LA, Witt MD, et al. The impact of impaired kidney function and HIV infection on the risk of anemia. AIDS Res Hum Retroviruses. 2012;28(12):1666\u201371.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"8394_CR19","doi-asserted-by":"crossref","unstructured":"Le T, Ly VT, Thu NTM, Nguyen A, Thanh NT, Chau NVV, et al. Population Pharmacodynamics of Amphotericin B Deoxycholate for disseminated infection caused by Talaromyces marneffei. Antimicrob Agents Chemother. 2019;63(2):e01739-18.","DOI":"10.1128\/AAC.01739-18"},{"issue":"1","key":"8394_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/ajkd.1998.v31.pm9428460","volume":"31","author":"AS De Vriese","year":"1998","unstructured":"De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features. Am J Kidney Dis. 1998;31(1):108\u201315.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"8394_CR21","first-page":"2234","volume":"7","author":"FS Lin","year":"2015","unstructured":"Lin FS, Wu MY, Tu WJ, Pan HQ, Zheng J, Shi JW, et al. A cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis treatment. J Thorac Dis. 2015;7(12):2234\u201342.","journal-title":"J Thorac Dis"},{"issue":"5","key":"8394_CR22","doi-asserted-by":"publisher","first-page":"e0010388","DOI":"10.1371\/journal.pntd.0010388","volume":"16","author":"M Shi","year":"2022","unstructured":"Shi M, Lin J, Wei W, et al. Machine learning-based in-hospital mortality prediction of HIV\/AIDS patients with Talaromyces marneffei infection in Guangxi, China. PLoS Negl Trop Dis. 2022;16(5):e0010388.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"8394_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1182\/blood-2005-06-2564","volume":"107","author":"EJ Yeo","year":"2006","unstructured":"Yeo EJ, Ryu JH, Cho YS, et al. Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1. Blood. 2006;107(3):916\u201323.","journal-title":"Blood"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08394-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T09:04:08Z","timestamp":1700211848000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08394-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8394"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08394-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1269438\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-1269438\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"19 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The independent ethics committee of each participating hospital approved the trial protocol (Chongqing Public Health Medical Center, Beijing Youan Hospital of Capital Medical University, Harbin Medical University, the First Hospital of Changsha, Guangzhou Eighth People\u2019s Hospital, Liuzhou General Hospital, the Third People\u2019s Hospital of Guilin, the Third People\u2019s Hospital of Shenzhen, Guiyang Public Health Clinical Center, Kunming Third People\u2019s Hospital, Yunnan Provincial Infectious Disease Hospital, the Fourth People\u2019s Hospital of Nanning, Guangxi Longtan Hospital, the First Affiliated Hospital of Zhejiang University, and Xixi Hospital of Hangzhou). The study was performed in accordance with the Helsinki Declaration of 1964,and its later amendments. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of authors agree to submit the manuscript for possible publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"707"}}